These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 15577023)

  • 1. [Bone quality and raloxifene].
    Nakamura T
    Clin Calcium; 2004 Apr; 14(4):632-7. PubMed ID: 15577023
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of SERMs on bone health. Effects of raloxifene and bisphosphonate on bone quality in osteoporosis: collagen cross-links, mineralization, and bone strength].
    Saito M
    Clin Calcium; 2010 Mar; 20(3):345-54. PubMed ID: 20190364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Defining the role of raloxifene as a therapeutic agent for postmenopausal osteoporosis: focus on its pharmacological properties].
    Ohta H
    Clin Calcium; 2004 Oct; 14(10):73-80. PubMed ID: 15577135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between changes in biochemical markers of bone turnover and prediction value of fracture risk].
    Cyaki O
    Clin Calcium; 2004 Oct; 14(10):39-46. PubMed ID: 15577130
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [SERM and quality of bone].
    Sohen S
    Clin Calcium; 2004 Oct; 14(10):96-9. PubMed ID: 15577138
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Evidence for the selective estrogen receptor modulator raloxifene--its pharmacological characteristics, efficacy and safety profiles].
    Ohta H
    Nihon Rinsho; 2009 May; 67(5):960-6. PubMed ID: 19432117
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Effect of raloxifene as a SERM on bone metabolism].
    Ohta H
    Nihon Rinsho; 2006 Apr; 64 Suppl 4():411-8. PubMed ID: 16689343
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of the effects of genistein, estradiol and raloxifene on the murine skeletal system.
    Sliwiński L; Folwarczna J; Nowińska B; Cegieła U; Pytlik M; Kaczmarczyk-Sedlak I; Trzeciak H; Trzeciak HI
    Acta Biochim Pol; 2009; 56(2):261-70. PubMed ID: 19401787
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Raloxifene for prevention of osteoporotic fractures.
    Diehr S; Mijal S; Nashelsky J
    Am Fam Physician; 2005 Jul; 72(1):132-4. PubMed ID: 16035693
    [No Abstract]   [Full Text] [Related]  

  • 10. Who will benefit from treatment with selective estrogen receptor modulators (SERMs)?
    Sambrook P
    Best Pract Res Clin Rheumatol; 2005 Dec; 19(6):975-81. PubMed ID: 16301191
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Contribution of bone quality to fracture risk].
    Mori S
    Clin Calcium; 2004 Oct; 14(10):33-8. PubMed ID: 15577129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Raloxifene: bone and cardiovascular effects.
    Francucci CM; Romagni P; Boscaro M
    J Endocrinol Invest; 2005; 28(10 Suppl):85-9. PubMed ID: 16550730
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of estrogen and selective estrogen receptor modulators in anti-aging].
    Ohta H
    Clin Calcium; 2008 Jul; 18(7):986-94. PubMed ID: 18591752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [SERMs: an update for clinicians].
    Ohta H
    Clin Calcium; 2005 Apr; 15(4):637-42. PubMed ID: 15802777
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of bone metabolism related genes polymorphisms with the effect of raloxifene hydrochloride on bone mineral density and bone turnover markers in postmenopausal women with osteoporosis.
    Zhang ZL; He JW; Qin YJ; Huang QR; Liu YJ; Hu YQ; Li M
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Apr; 23(2):129-33. PubMed ID: 16604479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Who are the candidates for the treatment by raloxifen ?].
    Hagino H
    Clin Calcium; 2004 Oct; 14(10):111-3. PubMed ID: 15577141
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Which is the better choice, estrogen or SERMs in postmenopausal women?].
    Shintani M
    Clin Calcium; 2004 Oct; 14(10):105-10. PubMed ID: 15577140
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Raloxifene and bone quality issues].
    Ohta H
    Clin Calcium; 2005 Jun; 15(6):1012-9. PubMed ID: 15930716
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Raloxifene use in clinical practice: efficacy and safety.
    Goldstein SR; Duvernoy CS; Calaf J; Adachi JD; Mershon JL; Dowsett SA; Agnusdei D; Stuenkel CA
    Menopause; 2009; 16(2):413-21. PubMed ID: 19092711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [SERMs for treatment of osteoporosis: state-of-the-art and perspectives].
    Legrand E; Hoppé E; Chappard D; Audran M
    Gynecol Obstet Fertil; 2006 May; 34(5):423-8. PubMed ID: 16697240
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.